Email this article to a friend

Printable Version

Articles Related to This Article: • Where's the health in health care reform? • The Honest Food Guide empowers consumers with independent information about foods and health • The inside scoop: Natural Health Products Expo West industry event NaturalNews Store Specials: • Raw organic Vanilla powder at 40% off • Revolutionary new Hurom Slow Juicer at the lowest price on the 'net + FREE shipping! • Certified Organic Nutiva Hemp Seeds at a huge discount (+ FREE bottle of hemp oil) See more at the NN store...

(NaturalNews) A recent report released by the Canadian Centre for Policy Alternatives criticizes Health Canada's drug safety regulations, claiming that Canadians are at risk due to speedy approval procedures and negligent safety profiling once the drugs are on the market.

"In Canada 3-4% of drugs approved will eventually be withdrawn from the market because of safety issues and the number of people exposed to these drugs is increasing because of aggressive marketing tactics by the pharmaceutical industry," says author Joel Lexchin, in a summary of the report, which is entitled Drug Safety and Health Canada: Going, Going... Gone?

According to his report, there are limitations to the Food and Drugs Act in Canada. Health Canada has the power to cancel market authorization for drugs prior to approval, and it can issue a public warning without the manufacturer's agreement, he writes. But it cannot force drug companies to recall drugs from pharmacy shelves, nor can it compel a company to revise its product labeling to update safety information.

The report claims that these limitations are due to Health Canada's favoring rapid approval times for new drugs, showing the regulatory organization's misguided priorities.

Dr. Lexchin, who teaches at Toronto's York University and who has consulted on pharmaceutical issues for the province of Ontario and the World Health Organization, offers a number of suggestions for improving Health Canada's post-marketing pharmaco-surveillance system, including:

• Health Canada needs to devote significantly more resources to its post-marketing pharmaco-surveillance system.


• Health Canada should undertake a systematic study to examine whether faster drug approvals lead to more post-marketing safety issues.


• Health Canada needs to publicly and transparently explain what criteria it uses in issuing safety communications.


• Health Canada needs to stop treating safety information as confidential and commit to making all safety information publicly available promptly after approving a new drug.

About the author

Related CounterThink Cartoons:

Related Articles: • Where's the health in health care reform? • The Honest Food Guide empowers consumers with independent information about foods and health • The inside scoop: Natural Health Products Expo West industry event	Take Action: Support NaturalNews.com Email this article to a friend Share this article on: NewsVine | digg | del.icio.us Permalink to this article: http://www.NaturalNews.com/026636_health_drugs_food.html Reprinting this article: Non-commercial use OK, cite NaturalNews.com with clickable link. Embed article link: (copy HTML code below): <a href = "http://www.NaturalNews.com/026636_health_drugs_food.html">Drug Approvals in Canada Put Speed Ahead of Public Safety</a>